Samsung Biologics promotes new CEO from within to head next phase of rapid manufacturing expansion

Conner Mitchell

Riding a wave of red-hot investments in biologics, Samsung Biologics — the biopharma CDMO arm of the South Korean tech giant — is stringing together a series …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Samsung Biologics promotes new CEO from within to head next phase of rapid manufacturing expansion

Conner Mitchell

Sign up to read this article for free.

Pfizer’s prostate cancer data leak shows promising results in early-stage study

Novartis returns for its anticoagulant in up to $3.1B buy of Blackstone’s Anthos

Judge halts some NIH cuts after 22 states sue

Vertex operations chief Stuart Arbuckle to retire

Merck KGaA confirms interest in acquiring cancer biotech SpringWorks

Reducing risk in drug development: The importance of validated MRD testing in lymphoid cancers

Sam­sung Bi­o­log­ics pro­motes new CEO from with­in to head next phase of rapid man­u­fac­tur­ing ex­pan­sion

Conner Mitchell

Sign up to read this article for free.

Pfiz­er’s prostate can­cer da­ta leak shows promis­ing re­sults in ear­ly-stage study

No­var­tis re­turns for its an­ti­co­ag­u­lant in up to $3.1B buy of Black­stone’s An­thos

Judge halts some NIH cuts af­ter 22 states sue

Ver­tex op­er­a­tions chief Stu­art Ar­buck­le to re­tire

Mer­ck KGaA con­firms in­ter­est in ac­quir­ing can­cer biotech Spring­Works

Re­duc­ing risk in drug de­vel­op­ment: The im­por­tance of val­i­dat­ed MRD test­ing in lym­phoid can­cers

Samsung Biologics promotes new CEO from within to head next phase of rapid manufacturing expansion

Pfizer’s prostate cancer data leak shows promising results in early-stage study

Novartis returns for its anticoagulant in up to $3.1B buy of Blackstone’s Anthos

Judge halts some NIH cuts after 22 states sue

Vertex operations chief Stuart Arbuckle to retire

Merck KGaA confirms interest in acquiring cancer biotech SpringWorks

Reducing risk in drug development: The importance of validated MRD testing in lymphoid cancers